News

Cidara Therapeutics to Share Key Financial Insights Soon

Cidara Therapeutics to Share Key Financial Insights Soon

Cidara Therapeutics Announces Upcoming Financial Results

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a pioneering biotechnology firm based in San Diego, has exciting news for its stakeholders. The company is set to report its first quarter 2025 financial performance along with essential operational highlights. This announcement will come after the close of the U.S. financial markets on May 8, 2025.

Engaging with Investors

To keep investors and interested parties informed, Cidara will host a conference call and live webcast at 5:00 PM Eastern Time on the same day. This platform will allow the leadership team to discuss the financial results in detail and provide insights into the company's operational progress.

Conference Call Details

For those wishing to participate in this important conference call, here are the key details:

Date and Time

The conference call is scheduled for Thursday, May 8, 2025, at 5:00 PM Eastern Time.

How to Join the Call

Attendees can dial in using the following numbers:

  • United States: 1-800-717-1738
  • International: 1-646-307-1865

Make sure to have the conference ID ready, which is 90743, to ensure smooth access to the call.

About Cidara Therapeutics

Cidara Therapeutics is committed to harnessing its innovative Cloudbreak platform to advance the development of drug-Fc conjugates (DFCs). These DFCs are unique therapeutic agents consisting of targeted small molecules or peptides attached to a proprietary human antibody fragment. One of their flagship products, CD388, is a long-acting antiviral that aims for universal prevention of seasonal and pandemic influenza from a single dose by directly inhibiting viral replication.

Recent Developments

In recent months, Cidara achieved significant milestones. The FDA granted Fast Track Designation for CD388, highlighting its potential to address public health needs efficiently. Furthermore, the company successfully enrolled patients in Phase 2b clinical trials by December 2024, marking a significant step forward in the product development pipeline.

Expanding Horizons in Oncology

Cidara is not just focused on antiviral solutions; it is also venturing into oncology with additional DFCs in development. Recently, in July 2024, they received Investigational New Drug (IND) clearance for CBO421, which targets CD73 in solid tumors. This development represents Cidara's dedication to expanding the boundaries of treatment options available in the oncology landscape.

Contact Information

For further inquiries, Cidara has made available the following contacts:

Investor Relations

Brian Ritchie from LifeSci Advisors can be reached at (212) 915-2578 for more details on investor-related questions.

Media Relations

For media inquiries, Michael Fitzhugh from LifeSci Communications is available via email at mfitzhugh@lifescicomms.com.

Frequently Asked Questions

What is the main purpose of the upcoming conference call?

The conference call will discuss Cidara's financial results and provide updates on operational highlights.

When is the conference call scheduled?

The call is scheduled for May 8, 2025, at 5:00 PM Eastern Time.

How can investors participate in the call?

Investors can join the call by dialing the provided United States or International numbers along with the conference ID.

What are DFCs produced by Cidara Therapeutics?

Drug-Fc conjugates are innovative therapeutic agents designed by Cidara that combine targeting molecules with human antibody fragments.

What is the significance of CD388?

CD388 is a key product aimed at preventing influenza and has received Fast Track Designation by the FDA, highlighting its critical potential in public health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tabañero Spices Up Holidays with $10 Gift Sets

Updated Category News Views 101

Hot Sauce, Spicy Gifting, and Bold Barbecue When holiday cheer mixes with a dash of heat, you end up with something as electrifying as Tabañero's latest offerings. This Florida-based player is nudging its way into the gift-giving scene with a lineup that's as spicy as it is thoughtful. Frankly, if you're scrambling for stocking stuffers or a memorable Secret Santa...

Continue Reading
Grupo Simec 2026 Nine-Month Financial Surge Spells Change

Updated Category News Views 44

Sharp Climb in Net Income Sparks Interest Buckle up, folks. Grupo Simec's nine-month results for 2026 are a mixed bag of surprises and steady flows. Let’s break it down: the net income skyrocketed by a whopping 428% compared to the same period last year—jumping from Ps. 763 million to Ps. 4,028 million. That's a solid leap, and it’s largely due to turning a hefty...

Continue Reading
Small Biz Financing Soars Amid Credit Struggles

Updated Category News Views 64

Record Financing Applications, But Not All is Rosy Diving headlong into this 1West data is like clutching at a double-edged sword. On one side, we've got record-breaking numbers—48,975 financing applications in Q3 alone. That’s a staggering 25% hike over last year. But before you pop the champagne, let's pivot to the other edge: dwindling financial health. With the...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 42

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Veterinary Implants Market to Hit $0.98B by 2031

Updated Category News Views 53

Veterinary Implants Market: A Growth Tale Something's stirring in the veterinary world, my friend. The Veterinary Implants Devices Market is hitting some serious strides, and we're looking at a valuation touching nearly $0.98 billion by 2031. If you're eyeing the veterinary sector, it's time to sharpen those pencils and take notes on where the trend winds are blowing....

Continue Reading
MetroScape: Local Roots Fuel Bold DFW Growth Plans

Updated Category News Views 118

A Local Business with Big Aspirations Here's the deal, folks: Local guys Dr. Marc Nickell and Chris Brewer snatched up MetroScape Landscape like it was the last slice of grandma's pie. Why? Not just for the greenbacks—they're putting down roots in their very own backyard, the Dallas-Fort Worth area. What Does Local Really Mean? Look, it's one thing hitting up a...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 72

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 65

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Mission Wealth's Rising Stars Shine Bright in 2026

Updated Category News Views 53

The financial world can be a ruthless arena, especially when you're under 40 and trying to make your mark. But in 2026, two up-and-comers from Mission Wealth are doing just that—earning spots on the coveted InvestmentNews Rising Stars list. Spotlight on Kulha and Dragan Andrew Kulha, with his legal and financial acumen, breaks down estate strategies like a seasoned...

Continue Reading
West Fraser Tackles Grim Quarter: Indefinite Mill Closures

Updated Category News Views 91

Bracing For Impact: The Tough Truth About West Fraser's Recent Moves Things are looking a bit bleak over at West Fraser Timber Co. They've just dropped their Q3 2026 results, ringing the bell with a hefty $80 million loss. As if that wasn't enough, the company's decided to indefinitely curtail a couple of mills—one in Lanett, Alabama and the other in Leola, Arkansas....

Continue Reading

Top 5 Most Recently Viewed Articles

What a Trump Win Could Mean for European Defence Stocks

Updated Category News Views 33

Potential Impact of a Trump Win on European Defence Stocks A Donald Trump victory in upcoming elections is generating significant interest among investors, particularly concerning European defence stocks. Many analysts believe that Trump's approach to military support and spending could present a lucrative 'buy-the-dip' opportunity. Trump's historical stances suggest he...

Continue Reading
Advenica: Rising Star in Secure File Transfer Market

Updated Category News Views 15

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Continue Reading
Century Fire Protection Strengthens Reach in Western U.S. Market

Updated Category News Views 438

Century Fire Protection Strengthens Its Geographic Presence In a strategic move to expand its reach, Century Fire Protection, a subsidiary of FirstService Corporation (NASDAQ: FSV), has recently completed the acquisition of TST Fire Protection, Inc. and Alliance Fire & Safety, both significant players in the fire protection industry based in Utah. Details of the...

Continue Reading
AST SpaceMobile Marks Milestone as Markets Reach New Heights

Updated Category News Views 81

Markets Rally to All-Time Highs U.S. equity markets have surged to new heights recently, with both the S&P 500 and Nasdaq indices recording notable gains. The December rally was fueled by easing inflation concerns, steady interest rates, and robust performance from major technology firms. Market Dynamics and Investor Sentiment The upward movement in the equity markets...

Continue Reading
Invesco High Income Fund Set for Liquidation Process

Updated Category News Views 67

Invesco High Income Fund Liquidation Announcement Invesco Advisers, Inc., a well-known subsidiary of Invesco Ltd., has officially announced additional details regarding the liquidation of its Invesco High Income 2024 Target Term Fund (IHTA). This follows the firm’s dedication to transparency and adherence to its stated investment objectives. Details on Fund Termination...

Continue Reading